NewAmsterdam Pharma Co N.V.
NAMSW· Nasdaq
NewAmsterdam Pharma Co N.V.
- Close
- Jun 30, 2026
- Market cap
- —
- no share count on file
- Filings
- 412
Price
Jun 30, 2026 · 13F quarter end
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $22,503,000 | reported | |
| FY 2024 | 2024-12-31 | $45,563,000 | reported | |
| FY 2023 | 2023-12-31 | $14,090,000 | reported | |
| FY 2022 | 2022-12-31 | $102,694,000 | reported |
NewAmsterdam Pharma Co N.V. · CIK 1936258 · Engraved from SEC EDGAR
